1. A holding plate for automatic transmission mounted in an automatic transmission of an automotive vehicle and configured to hold wires, characterized in that:
the holding plate is formed with a support surface for holding the wires, a pair of through holes, through which a tie band for tying the wires is inserted, is formed on the support surface, the through holes are formed to be able to hold the wires in a tied state by allowing a free end side of a band portion of the tie band to be successively inserted therethrough and locked to a lock portion formed on an opposite end part of the band portion, and the pair of through holes are formed to have mutually different shapes; and
out of the pair of through holes, the one through which the free end side of the band portion is first inserted includes a general part through which the free end side of the band portion is insertable and an extended part communicating with the general part and formed by extending the general part.
2. The holding plate for automatic transmission of claim 1, wherein, out of the pair of through holes, the other through which the free end part of the band portion is not first inserted is formed to be open sideways by cutting a side edge of the support surface.
3. (canceled)
4. The holding plate for automatic transmission of claim 2, wherein the extended part is arranged at a side of the general part opposite to a side toward which the wires are pulled as being tied by the tie band.
5. The holding plate for automatic transmission of claim 4, wherein the extended part is formed to have a curved hole edge.
6. A wiring unit mounted in an automatic transmission of an automotive vehicle and configured to execute a control relating to a speed changing operation, comprising the holding plate for automatic transmission of claim 5.
7. The holding plate for automatic transmission of claim 1, wherein the extended part is arranged at a side of the general part opposite to a side toward which the wires are pulled as being tied by the tie band.
8. The holding plate for automatic transmission of claim 7, wherein the extended part is formed to have a curved hole edge.
9. A wiring unit mounted in an automatic transmission of an automotive vehicle and configured to execute a control relating to a speed changing operation, comprising the holding plate for automatic transmission of claim 8.
10. The holding plate for automatic transmission of claim 2, wherein the extended part is formed to have a curved hole edge.
11. A wiring unit mounted in an automatic transmission of an automotive vehicle and configured to execute a control relating to a speed changing operation, comprising the holding plate for automatic transmission claim 10.
12. The holding plate for automatic transmission of claim 1, wherein the extended part is formed to have a curved hole edge.
13. A wiring unit mounted in an automatic transmission of an automotive vehicle and configured to execute a control relating to a speed changing operation, comprising the holding plate for automatic transmission of claim 12.
14. A wiring unit mounted in an automatic transmission of an automotive vehicle and configured to execute a control relating to a speed changing operation, comprising the holding plate for automatic transmission of claim 1.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. A compound of formula (Ia)
33
wherein R1, R2, R3, and R4 independently of each other represent hydrogen, halogen, perhalomethyl, hydroxy, nitro, cyano, formyl, or C1-12alkyl, C4-12-alkenynyl, C2-12-alkenyl, C2-12-alkynyl, C1-12alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, acyloxy, hydroxyC1-12alkyl, amino, acylamino, C1-12alkyl-amino, arylamino, aralkylamino, aminoC1-12alkyl, C1-12alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, C1-12alkoxyC1-12alkyl, aryloxyC1-12alkyl, aralkoxyC1-12alkyl, C1-12alkylthio, thioC1-12alkyl, C1-12alkoxycarbonylamino, aryloxycarbonylamino, aralkoxycarbonylamino, COR11, or SO2R12, wherein R11 and R12 independently of each other are selected from hydroxy, halogen, perhalomethyl, C1-6alkoxy or amino optionally substituted with one or more C1-6alkyl, perhalomethyl or aryl; optionally substituted with one or more halogen, perhalomethyl, hydroxy, nitro or cyano;
or R1 and R2, R2 and R3 andor R3 and R4 may form a cyclic ring containing from 5 to 7 carbon atoms optionally substituted with one or more C1-6alkyl;
ring A represents a 5-6 membered cyclic ring, optionally substituted with one or more halogen, perhalomethyl, hydroxy, nitro, cyano, formyl, or C1-12alkyl, C4-12-alkenynyl, C2-12-alkenyl, C2-12-alkynyl, C1-12alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, acyloxy, hydroxyC1-12alkyl, amino, acylamino, C1-12alkyl-amino, arylamino, aralkylamino, aminoC1-12alkyl, C1-12alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, C1-12alkoxyC1-12alkyl, aryloxyC1-12alkyl, aralkoxyC1-12alkyl, C1-12alkylthio, thioC1-12alkyl, C1-12alkoxycarbonylamino, aryloxycarbonylamino, aralkoxycarbonylamino, COR11, or SO2R12, wherein R11 and R12 independently of each other are selected from hydroxy, halogen, perhalomethyl, C1-12alkoxy or amino optionally substituted with one or more C1-6alkyl, perhalomethyl or aryl; optionally substituted with one or more halogen, perhalomethyl, hydroxy, nitro or cyano;
X is a valence bond, (CHR9), (CHR9)CH2, CHCH, O, O(CHR9), S(CHR9), (NR9)CH2, (CHR9)CHCH, (CHR9)CH2CH2, (CO), OCH2O, (NR9), (NR9)S(O2), CH(CR9), (CO)(CHR9), CH2(SO), S, (SO), (SO2), CH2(SO2), CH2OCH2, wherein R9 is hydrogen, halogen, hydroxy, nitro, cyano, formyl, C1-12alkyl, C1-12alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, acyloxy, hydroxyalkyl, amino, acylamino, C1-12alkyl-amino, arylamino, aralkylamino, aminoC1-12alkyl, C1-12alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, C1-12alkoxyC1-12alkyl, aryloxyC1-12alkyl, aralkoxyC1-12alkyl, C1-12alkylthio, thioC1-12alkyl, C1-12alkoxycarbonylamino, aryloxycarbonylamino, aralkoxycarbonylamino, COR13, or SO2R14, wherein R13 and R14 independently of each other are selected from hydroxy, halogen, C1-6alkoxy, amino optionally substituted with one or more C1-6alkyl, perhalomethyl or aryl;
T is >N, >CH, >C<, CH2N<;
Z is CH2, CH, >N, O, S, >CO, >SO, >SO2, >NR15, wherein R15 is hydrogen, halogen, hydroxy, nitro, cyano, formyl, C1-12alkyl, C1-12alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, acyloxy, hydroxyalkyl, amino, acylamino, C1-12alkyl-amino, arylamino, aralkylamino, aminoC1-12alkyl, C1-12alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, C1-12alkoxyC1-12alkyl, aryloxyC1-12alkyl, aralkoxyC1-12alkyl, C1-12alkylthio, thioC1-12alkyl, C1-12alkoxycarbonylamino, aryloxycarbonylamino, aralkoxycarbonylamino, COR16, or SO2R17, wherein R16 and R17 independently of each other are selected from hydroxy, halogen, C1-6alkoxy, amino optionally substituted with one or more C1-6alkyl, perhalomethyl or aryl;
Q is O, S, >NR18, wherein R18 is hydrogen, halogen, hydroxy, nitro, cyano, formyl, C1-12alkyl, C1-12alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryi, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, acyloxy, hydroxyalkyl, amino, acylamino, C1-12alkyl-amino, arylamino, aralkylamino, aminoC1-12alkyl, C1-12alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, C1-12alkoxyC1-12alkyl, aryloxyC1-12alkyl, aralkoxyC1-12alkyl, C1-12alkylthio, thioC1-12alkyl, C1-12alkoxycarbonylamino, aryloxycarbonylamino, aralkoxycarbonylamino, COR19, or SO2R20, wherein R19 and R20 independently of each other are selected from hydroxy, halogen, C1-6alkoxy, amino optionally substituted with one or more C1-6alkyl, perhalomethyl or aryl;
U is O, S, >SO2, >NR21, wherein R21 is hydrogen or C1-6alkyl;
T(Z)p represents a single bond or a double bond;
Ar represents arylene, heteroarylene, or a divalent heterocyclic group optionally substituted with one or more C1-6alkyl or aryl;
R5 represents hydrogen, hydroxy, halogen, C1-12alkoxy, C1-12alkyl, C4-12-alkenynyl, C2-12-alkenyl, C2-12-alkynyl or aralkyl; optionally substituted with one or more halogen, perhalomethyl, hydroxy, nitro or cyano; or R5 forms a bond together with R6;
R6 represents hydrogen, hydroxy, halogen, C1-12alkoxy, C1-12alkyl, C4-12-alkenynyl, C2-12-alkenyl, C2-12-alkynyl, acyl or aralkyl; optionally substituted with one or more halogen, perhalomethyl, hydroxy, nitro or cyano; or R8 forms a bond together with R5;
R7 represents hydrogen, C1-12alkyl, C4-12-alkenynyl, C2-12-alkenyl, C2-12-alkynyl, aryl, aralkyl, C1-12alkoxyC1-12alkyl, C1-12alkoxycarbonyl, aryloxycarbonyl, C1-12alkylaminocarbonyl, arylaminocarbonyl, acyl, heterocyclyl, heteroaryl or heteroaralkyl groups; optionally substituted with one or more halogen, perhalomethyl, hydroxy, nitro or cyano;
R8 represents hydrogen, C1-12alkyl, C4-12-alkenynyl, C2-12-alkenyl, C2-12-alkynyl, aryl, aralkyl, heterocyclyl, heteroaryl or heteroaralkyl groups; optionally substituted with one or more halogen, perhalomethyl, hydroxy, nitro or cyano;
Y represents oxygen, sulphur or NR10, where R10 represents hydrogen, C1-12alkyl, aryl, hydroxyC1-12alkyl or aralkyl groups or when Y is NR10, R8 and R10 may form a 5 or 6 membered nitrogen containing ring, optionally substituted with one or more C1-6alkyl;
n is an integer ranging from 1 to 4;
p is an integer ranging from 0 to 1;
or a pharmaceutically acceptable salt thereof.
2. A compound of claim 1 wherein R1, R2, R3, and R4 independently of each other represent hydrogen, halogen, perhalomethyl, hydroxy, cyano, or C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, C1-7alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, acyloxy, hydroxyC1-7alkyl, amino, acylamino, C1-7alkyl-amino, arylamino, aralkylamino, aminoC1-7alkyl, C1-7alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, C1-7alkoxyC1-7alkyl, aryloxyC1-7alkyl, aralkoxyC1-7alkyl, C1-7alkylthio, thioC1-7alkyl, C1-7alkoxycarbonylamino, aryloxycarbonylamino, aralkoxycarbonylamino, COR11, or SO2R12, wherein R11 and R12 independently of each other are selected from hydroxy, perhalomethyl, C1-6alkoxy or amino optionally substituted with one or more C1-6alkyl, perhalomethyl or aryl; optionally substituted with one or more halogen, perhalomethyl, hydroxy, nitro or cyano;
or R1 and R2, R2 and R3 andor R3 and R4 may form a cyclic ring containing from 5 to 7 carbon atoms optionally substituted with one or more C1-6alkyl.
3. A compound of claim 1 wherein R1, R2, R3, and R4 independently of each other represent hydrogen, halogen, perhalomethyl, hydroxy, cyano, or C1-7alkyl, C4-7-alkenynyl, C27-alkenyl, C2-7-alkynyl, C1-7alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, hydroxyC1-7alkyl, amino, acylamino, C1-7alkyl-amino, arylamino, aralkylamino, aminoC1-7alkyl, C1-7alkoxyC1-7alkyl, aryloxyC1-7alkyl, aralkoxyC1-7alkyl, C1-7alkylthio, thioC1-7alkyl, C1-7alkoxycarbonylamino, aryloxycarbonylamino or aralkoxycarbonylamino.
4. A compound of claim 1 wherein R1, R2, R3, and R4 independently of each other represent hydrogen, halogen, perhalomethyl, hydroxy, cyano, or C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, C1-7alkoxy, aryl, aryloxy, aralkyl, aralkoxy, acyl, hydroxyC1-7alkyl, amino, C1-7alkyl-amino, arylamino, aralkylamino, C1-7alkoxyC1-7alkyl, aryloxyC1-7alkyl, aralkoxyC1-7alky or C1-7alkylthio.
5. A compound of claim 1 wherein R1, R2, R3, and R4 independently of each other represent hydrogen, halogen, perhalomethyl, or C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, aryl, aralkyl, hydroxyC1-7alkyl, C1-7alkoxyC1-7alkyl, aryloxyC1-7alkyl or aralkoxyC1-7alkyl.
6. A compound of claim 1 wherein R1, R2, R3, and R4 independently of each other represent hydrogen, halogen or C1-7alkyl.
7. A compound of claim 1 wherein R1, R2, R3, and R4 represent hydrogen.
8. A compound of claim 1 wherein ring A represents a 5-6 membered cyclic ring, optionally substituted with one or more halogen, perhalomethyl, hydroxy, cyano, or C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, C1-7alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, acyloxy, hydroxyC1-7alkyl, amino, acylamino, C1-7alkyl-amino, arylamino, aralkylamino, aminoC1-7alkyl, C1-7alkoxyC1-7alkyl, aryloxyC1-7alkyl, aralkoxyC1-7alkyl, C1-7alkylthio, thioC1-7alkyl, C1-7alkoxycarbonylamino, aryloxycarbonylamino, aralkoxycarbonylamino, COR11, or SO2R12, wherein R11 and R12 independently of each other are selected from hydroxy, perhalomethyl, C1-6alkoxy or amino optionally substituted with one or more C1-6alkyl, perhalomethyl or aryl; optionally substituted with one or more halogen, perhafomethyl, hydroxy or cyano.
9. A compound of claim 1 wherein ring A represents a 5-6 membered cyclic ring, optionally substituted with one or more halogen, perhalomethyl, hydroxy, cyano, or C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, C1-7alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, hydroxyC1-7alkyl, amino, acylamino, C1-7alkyl-amino, arylamino, aralkylamino, aminoC1-7alkyl, C1-7alkoxyC1-7alkyl, aryloxyC1-7alkyl, aralkoxyC1-7alkyl, C1-7alkylthio, thioC1-7alkyl, C1-7alkoxycarbonylamino, aryloxycarbonylamino or aralkoxycarbonylamino.
10. A compound of claim 1 wherein ring A represents a 5-6 membered cyclic ring, optionally substituted with one or more halogen, perhalomethyl, hydroxy, cyano, or C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, C1-7alkoxy, aryl, aryloxy, aralkyl, aralkoxy, acyl, hydroxyC1-7alkyl, amino, C1-7alkyl-amino, arylamino, aralkylamino, C1-7alkoxyC1-7alkyl, aryloxyC1-7alkyl, aralkoxyC1-7alkyl or C1-7alkylthio.
11. A compound of claim 1 wherein ring A represents a 5-6 membered cyclic ring, optionally substituted with one or more halogen, perhalomethyl or C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, C1-7alkoxy, aryl, aralkyl, hydroxyC1-7alkyl, C1-7alkoxyC1-7alkyl, aryloxyC1-7alkyl or aralkoxyC1-7alkyl.
12. A compound of claim 1 wherein ring A represents a 6 membered cyclic ring, optionally substituted with one or rriore chlorine or methyl groups.
13. A compound of claim 1 wherein ring A represent a phenyl ring.
14. A compound of claim 1 wherein X is a valence bond, (CHR9), (CHR9)CH2, CHCH, O, O(CHR9), S(CHR9), (NR9)CH2, (CHR9)CHCH, (CHR9)CH2CH2, (CO), OCH2O, (NR9)S(O2), (NR9), CH(CR9), (CO)(CHR9), CH2(SO), S, (SO), (SO2), CH2(SO2) or CH2OCH2, wherein R9 is hydrogen, halogen, hydroxy, C1-7alkyl, C1-7alkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, hydroxyalkyl, amino, acylamino, C1-7alkyl-amino, arylamino, aralkylamino, aminoC1-7alkyl, C1-7alkoxyC1-12alkyl, aryloxyC1-7alkyl, aralkoxyC1-7alkyl, C1-12alkylthio, thioC1-7alkyl, C1-7alkoxycarbonylamino, aryloxycarbonylamino or aralkoxycarbonylamino.
15. A compound of claim 1 wherein X is a valence bond, (CHR9), (CHR9)CH2, CHCH, O, O(CHR9), S(CHR9), (NR9)CH2, (CHR9)CHCH, (CHR9)CH2CH2, (CO), OCH2O, (NR9)S(O2), (NR9), CH(CR9), (CO)(CHR9), CH2(SO), S, (SO), (SO2), CH2(SO2) or CH2OCH2, wherein R9 is hydrogen, halogen, hydroxy, C1-7alkyl, aryl, aralkyl, C1-7alkoxyC1-12alkyl, aryloxyC1l7alkyl or aralkoxyC1-7alkyl.
16. A compound of claim 1 wherein X is a valence bond, (CHR9), (CHR9)CH2, CHCH, O, O(CHR9), S(CHR9), (NR9)CH2, (CHR9)CHCH, (CHR9)CH2CH2, (CO), OCH2O, (NR9)S(O2), (NR9), CH(CR9), (CO)(CHR9), CH2(SO), S, (SO), (SO2), CH2(SO2) or CH2OCH2, wherein R9 is hydrogen.
17. A compound of claim 1 wherein X is a valence bond, (CHR9), (CHR9)CH2, CHCH, O, O(CHR9), S(CHR9), (NR9)CH2, OCH2O, (NR9), S, (SO) or CH2OCH2, wherein R9 is hydrogen.
18. A compound of claim 1 wherein X is a valence bond, (CHR9), (CHR9)CH2, CHCH, O, O(CHR9), S(CHR9), (NR9)CH2, CCH2O, (NR9), S or CH2OCH2, wherein R9 is hydrogen.
19. A compound of claim 1 wherein X is a valence bond, (CHR9), (CHR9)CH2, CHCH, O, O(CHR9), S(CHR9), OCH2O or S, wherein R9 is hydrogen.
20. A compound of claim 1 wherein X is S.
21. A compound of claim 1 wherein T is >C<.
22. A compound of claim 1 wherein Z is CH2, CH, >N, O, S, >CO, >SO, >SO2.
23. A compound of claim 1 wherein Z is >N.
24. A compound of claim 1 wherein Q is O, S, >NR18, wherein R18 is hydrogen or C1-7alkyl.
25. A compound of claim 1 wherein Q is >NR18, wherein R18 is hydrogen.
26. A compound of claim 1 wherein U is O.
27. A compound of claim 1 wherein T(Z)p represents a double bond.
28. A compound of claim 1 wherein Ar represents arylene optionally substituted with one or more C1-6alkyl or aryl.
29. A compound of claim 1 wherein Ar is phenyl.
30. A compound of claim 1 wherein R5 represents hydrogen, hydroxy, halogen, C1-7alkoxy, C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl or aralkyl, or R5 forms a bond together with R6.
31. A compound of claim 1 wherein R5 represents hydrogen or R5 forms a bond together with R6.
32. A compound of claim 1 wherein R5 represents hydrogen, hydroxy, halogen, C1-7alkoxy, C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl or aralkyl, or R5 forms a bond together with R6.
33. A compound of claim 1 wherein R5 represents hydrogen or R5 forms a bond together with R6.
34. A compound of claim 1 wherein R7 represents hydrogen, C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, aryl, aralkyl, C1-7alkoxyC1-7alkyl, C1-7alkoxycarbonyl, aryloxycarbonyl, C1-7alkylaminocarbonyl, arylaminocarbonyl, acyl, heterocyclyl, heteroaryl or heteroaralkyl.
35. A compound of claim 1 wherein R7 represents hydrogen, C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl or C2-7-alkynyl.
36. A compound of claim 1 wherein R7 is C1-12alkyl.
37. A compound of claim 1 wherein R8 represents hydrogen, C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, aryl, aralkyl, heterocyclyl, heteroaryl or heteroaralkyl groups; optionally substituted with one or more halogen, perhalomethyl, hydroxy, nitro or cyano.
38. A compound of claim 1 wherein R8 represents hydrogen, C1-7alkyl, C4-7-alkenynyl, C2-7-alkenyl, C2-7-alkynyl, aryl or aralkyl.
39. A compound of claim 1 wherein R8 is hydrogen or C1-12alkyl.
40. A compound of claim 1 wherein Y represents oxygen, sulphur or NR10, where R10 represents hydrogen, C1-7alkyl, aryl, hydroxyC1-7alkyl or aralkyl groups.
41. A compound of claim 1 wherein Y is oxygen.
42. A compound of claim 1 wherein n is an integer ranging from 2 to 3.
43. A compound of claim 1 wherein p is 1.
44. A compound of claim 1 wherein A is benzo.
45. A compound of claim 1 wherein X is O.
46. A compound of claim 1 wherein X is S.
47. A compound of claim 1 wherein Z is S and p is 1.
48. A compound of claim 1 wherein Z is CH2 and p is 1.
49. A compound of claim 1 wherein X is CH and p is 1.
50. A compound of claim 1 wherein T(Z)p represents a single bond or a double bond.
51. A compound of claim 1 wherein T is >CH.
52. A compound of claim 1 wherein T is >C<.
53. A compound of claim 1 wherein Q is O.
54. A compound of claim 1 wherein Q is S.
55. A compound of claim 1 wherein Q is >NR18, wherein R18 is H.
56. A compound of claim 1 wherein n is 2.
57. A compound of claim 1 wherein U is O.
58. A compound of claim 1 wherein Ar is phenylene.
59. A compound of claim 1 wherein R5 is H.
60. A compound of claim 1 wherein R6 is H.
61. A compound of claim 1 wherein R7 is ethyl.
62. A compound of claim 1 wherein R8 is H.
63. A compound of claim 1 wherein p is 0.
64. A compound of claim 1 A is a five membered ring containing S.
65. A compound of claim 1 wherein X is (CHR9)CH2, wherein R9 is H.
66. A compound of claim 1 wherein X is O(CHR9), wherein R9 is H.
67. A compound of claim 1 wherein X is S(CHR9), wherein R9 is H.
68. A compound of claim 1 wherein X is OCH2O.
69. A compound of claim 1 which is:
2-Ethoxy-3-4-2-(11H-5-oxa-10-thia-dibenzoa,dcyclohepten-11-yloxy)-ethoxy-phenyl-propionic acid,
3-(4-2-(Dibenzob,f-1,4-thiazepin-11-ylamino)-ethoxy-phenyl)-2-ethoxy-propionic acid ethyl ester,
3-4-2-(Dibenzob,f1,4thiazepin-11-ylamino)-ethoxy-phenyl-2-ethoxy-propionic acid,
3-4-2-(10,11-Dihydro-dibenzob,fthiepin-10-ylsulfanyl)-ethoxy-phenyl-2-ethoxy-propionic acid,
3-(4-2-5H-Dibenzoa,dcyclohepten-5-yloxy)-ethoxy-phenyl)-2-ethoxy-propionic acid ethyl ester,
3-(4-2-(6,11-Dihydrodibenzob,ethiepin-11-yloxy)-ethoxy-phenyl)-2-ethoxy-propionic acid ethyl ester,
3-(4-2-(6,11-Dihydrodibenzob,ethiepin-11-yloxy)-ethoxy-phenyl)-2-ethoxy-propionic acid,
3-(4-2-(6,11-Dihydrodibenzob,eoxepin-11-yloxy)-ethoxy-phenyl)-2-ethoxy-propionic acid ethyl ester,
3-(4-2-(2,10-Dichloro-12H-5,7-dioxa-dibenzoa,dcycloocten-12-yloxy)-ethoxy-phenyl)-2-ethoxy-propionic acid ethyl ester,
3-(4-2-(2,10-Dichloro-12H-5,7-dioxa-dibenzoa,dcycloocten-12-yloxy)-ethoxy-phenyl)-2-ethoxy-propionic acid,
2-Ethoxy-3-(4-2-(2-methyl-9,1 0-dihydro-4H-1-oxa-3-aza-benzofazulen-4-yloxy)-ethoxy-phenyl)-propionic acid ethyl ester,
3-(4-2-(10,11-Dihydro-5H-dibenzoa,dcyclohepten-5-yloxy)-ethoxy-phenyl)-2-ethoxy-propanoic acid ethyl ester,
3-(4-2-(10,11-Dihydro-5H-dibenzoa,dcyclohepten-5-yloxy)-ethoxy-phenyl)-2-ethoxy-propanoic acid,
3-(4-2-(10,11-dihydro-5H-dibenzoa,dcyclohepten-5-yl-methyl-amino)-ethoxy-phenyl)-2-ethoxypropanoic acid ethyl ester, or
3-(4-2-(10,11-dihydro-5H-dibenzoa,dcyclohepten-5-yl-methyl-amino)-ethoxy-phenyl)-2-ethoxypropanoic acid;
or a pharmaceutically acceptable salt thereof.
70. A compound of claim 1 which is:
2-Ethoxy-3-4-2-(11H-5-oxa-10-thia-dibenzoa,dcyclohepten-11-yloxy)-ethoxy-phenyl-propionic acid,
3-4-2-(Dibenzob,f1,4thiazepin-11-ylamino)-ethoxy-phenyl-2-ethoxy-propionic acid, or
3-4-2-(10,11-Dihydro-dibenzob,fthiepin-10-ylsulfanyl)-ethoxy-phenyl-2-ethoxy-propionic acid;
or a pharmaceutically acceptable salt thereof.
71. A pharmaceutical composition comprising, as an active ingredient, an effective amount of a compound of claim 1 together with a pharmaceutically acceptable carrier or diluent.
72. The composition of claim 71 in unit dosage form, comprising from about 0.05 to about 100 mg of the compound.
73. The pharmaceutical composition of claim 71 wherein the route of administration is oral, nasal, transdermal, pulmonal, or parenteral.
74. A method of treating or preventing conditions mediated by nuclear receptors, the method comprising administering to a subject in need thereof an effective amount of a compound of claim 1.
75. The method of claim 74 wherein the nuclear receptors are the Peroxisome Proliferator-Activated Receptors (PPAR).
76. A method of treating or preventing diabetes or obesity, the method comprising administering to a subject in need thereof an effective amount of a compound of claim 1.
77. The method of claim 74, wherein the effective amount of the compound is in the range of from about 0.05 to about 100 mg per day.